AllQuantitative Report
logoArgusMarch 31, 2021

GKOS: Lowering target price to $68.00

Symbols
GKOS
Sector(s)
Healthcare
Rating
Current Price
$82.63
Price Target
$NaN
Earnings Estimate
Summary

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma.

Subscribe to Yahoo Finance Plus Essential for full access
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
Try it Free